Scholar Rock Holding (SRRK) Payables (2017 - 2026)
Scholar Rock Holding (SRRK) recorded quarterly Payables of $9.2 million in Q1 2026, down 10.53% quarter-over-quarter from $10.3 million in Q4 2025, and up 107.75% on a YoY basis from $4.4 million in Q1 2025.
Scholar Rock Holding (SRRK) Payables (2017 - 2026) Analysis & Trends
Scholar Rock Holding's Payables history runs 10 years deep, the most recent figure standing at $9.2 million for Q1 2026.
- In Q1 2026, Payables rose 107.75% year-over-year to $9.2 million; the TTM figure through Mar 2026 stood at $9.2 million (up 107.75% YoY), while the FY2025 annual figure was $10.3 million, up 2.06% from the prior year.
- Payables was $9.2 million for Q1 2026 at Scholar Rock Holding, down from $10.3 million in the prior quarter.
- In the past five years, Payables ranged from a high of $14.4 million in Q2 2022 to a low of $1.1 million in Q2 2025.
- Historically, Payables has averaged $6.1 million across 5 years, with a median of $4.8 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Payables surged 786.79% in 2022, then tumbled 78.9% in 2023.
- A 5-year view of Payables shows it stood at $4.0 million in 2022, then rose by 20.16% to $4.8 million in 2023, then jumped by 110.36% to $10.1 million in 2024, then increased by 2.06% to $10.3 million in 2025, then decreased by 10.53% to $9.2 million in 2026.
- The last three Payables figures came in at $9.2 million (Q1 2026), $10.3 million (Q4 2025), and $6.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.05 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 300,549.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 83.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 8.69 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 489.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 34.55 Mn |
| 10 | Scholar Rock Holding | 6.03 Bn | 5.55 Bn | - | 9.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.22 Mn |
| Dec 31, 2025 | 10.30 Mn |
| Sep 30, 2025 | 6.77 Mn |
| Jun 30, 2025 | 1.10 Mn |
| Mar 31, 2025 | 4.44 Mn |
| Dec 31, 2024 | 10.10 Mn |
| Sep 30, 2024 | 4.07 Mn |
| Jun 30, 2024 | 4.90 Mn |
| Mar 31, 2024 | 8.37 Mn |
| Dec 31, 2023 | 4.80 Mn |
| Sep 30, 2023 | 1.97 Mn |
| Jun 30, 2023 | 3.04 Mn |
| Mar 31, 2023 | 3.72 Mn |
| Dec 31, 2022 | 3.99 Mn |
| Sep 30, 2022 | 2.81 Mn |
| Jun 30, 2022 | 14.43 Mn |
| Mar 31, 2022 | 9.57 Mn |
| Dec 31, 2021 | 6.01 Mn |
| Sep 30, 2021 | 2.04 Mn |
| Jun 30, 2021 | 1.63 Mn |